We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

GENOMIC CANCER TESTING MARKET ANALYSIS

Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagnostics, Risk Assessment, Pharmacogenomic Testing), By Testing Setting (In-House Testing, Outsourced Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Dec 2023
  • Code : CMI5914
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Regional Analysis

Global genomic cancer testing market Regional Insights:

  • North America has emerged as a leader in the genomic cancer testing market, leveraging its well-established healthcare infrastructure and high awareness about precision medicine. The U.S., in particular, has witnessed significant advancements and widespread adoption of genomic testing in clinical practice. It is expected to dominate the market with a share of 37.5% in 2023. The region's growth is fueled by factors such as the high prevalence of cancer, increased investments in genomic cancer testing technologies, and the presence of numerous key players.
  • Europe has also been actively investing in precision medicine initiatives, including genomic cancer testing. Countries like the U.K., Germany, and France have made notable progress in integrating genomic testing into routine clinical care. In 2023, Europe is expected to be the second-largest market with a share of 30.4%. The region's growth is driven by the rising demand for personalized cancer care, increasing government initiatives, and the presence of a significant number of key players.
  • The Asia Pacific region demonstrates substantial growth potential in the genomic cancer testing market. Countries like China, Japan, and South Korea have been investing in genomic research and technology, leading to increased adoption of genomic testing in oncology. Asia-Pacific is anticipated to be the fastest-growing market during the forecast period, with a projected CAGR of 22.6%. Factors driving growth in the region include the rising prevalence of cancer, increasing investments in genomic cancer testing technologies, and growing awareness about the benefits of genomic cancer testing.
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.